Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Managing Partner, City Hill; Venture Partner, ARCH Venture Partners
Dr. Jonathan Lim is dedicated to building world-class, mission-driven ventures as Managing Partner at City Hill Ventures and Venture Partner at ARCH Venture Partners. Within the City Hill and ARCH portfolios, Jonathan serves as Chairman, CEO and Co-Founder of Erasca, which he co-founded in July 2018 with a mission to erase cancer; Chairman and Co-Founder of Boundless Bio; and Board Director of Maze Therapeutics. From 2003 to 2018, Jonathan was a leader and founding investor of four biotech companies that delivered seven approved therapeutic products for adult and pediatric indications in oncology, immunology and drug delivery benefitting thousands of patients globally, raised a combined $1 billion in capital and generated more than $4 billion of shareholder value (including consecutive acquisitions of Ignyta by Roche and Bonti by Allergan in 2018).